Advertisement

Congenital Muscular Dystrophy

Reference work entry

Congenital muscular dystrophy (CMD) refers to a group of genetic disorders in which weakness and an abnormal muscle biopsy are present at birth.

Synonyms and Related Disorders

Merosin-negative CMD; Merosin-positive CMD with mental retardation and neuronal migration defects (Fukuyama CMD, muscle-eye-brain disease, Walker-Warburg syndrome); Merosin-positive CMD (rigid spine disease, Ullrich disease, pure CMD)

Genetics/Basic Defects

  1. 1.
    Inheritance
    1. a.

      Genetic heterogeneity

       
    2. b.

      Most are autosomal recessive (Muntoni and Voit 2004)

       
     
  2. 2.

    Caused by genetic defects in proteins of the sarcolemmal membrane or its supporting structures. The proteins may also be expressed in the central nervous system, and many forms of CMD are associated with structural brain and eye anomalies

     
  3. 3.
    Classification of CMD according to biochemical defect (Cardamone et al. 2008)
    1. a.
      Extracellular matrix protein
      1. i.
        Merosin (lamin-α2) ( LAMA2): Merosin-deficient CMD (MDC1A)
        1. a)

          Demyelinating neuropathy

           
        2. b)

          White matter...

Keywords

Muscular Dystrophy Severe Mental Retardation Congenital Muscular Dystrophy Congenital Muscular Dystrophy Congenital Nystagmus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aida, N. (1998). Fukuyama congenital muscular dystrophy: A neuroradiologic review. Journal of Magnetic Resonance Imaging, 8, 317–326.PubMedCrossRefGoogle Scholar
  2. Allamand, V., & Guicheney, P. (2002). Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). European Journal of Human Genetics, 10, 91–94.PubMedCrossRefGoogle Scholar
  3. Brockington, M., Blake, D. J., Prandini, P., et al. (2001). Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. American Journal of Human Genetics, 69, 1198–1209.PubMedCrossRefGoogle Scholar
  4. Brockington, M., Sewry, C. A., Herrmann, R., et al. (2000). Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. American Journal of Human Genetics, 66, 428–435.PubMedCrossRefGoogle Scholar
  5. Brockington, M., Yuva, Y., Prandini, P., et al. (2001). Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Human Molecular Genetics, 10, 2851–2859.PubMedCrossRefGoogle Scholar
  6. Cardamone, M., Darras, B. T., & Ryan, M. M. (2008). Inherited Myopathies and muscular dystrophies. Seminars in Neurology, 28, 250–259.PubMedCrossRefGoogle Scholar
  7. Caro, P. A., Scavina, M., Hoffman, E., et al. (1999). MR imaging findings in children with merosin-deficient congenital muscular dystrophy. AJNR. American Journal of Neuroradiology, 20, 324–326.PubMedGoogle Scholar
  8. Chijiiwa, T., Nishimura, M., Inomata, H., et al. (1983). Ocular manifestations of congenital muscular dystrophy (Fukuyama type). Annals of Ophthalmology, 15(921–923), 926–928.Google Scholar
  9. Cormand, B., Avela, K., Pihko, H., et al. (1999). Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and Homozygosity mapping. American Journal of Human Genetics, 64, 126–135.PubMedCrossRefGoogle Scholar
  10. Cormand, B., Pihko, H., Bayés, M., et al. (2001). Clinical and genetic distinction between Walker–Warburg syndrome and muscle-eye-brain disease. Neurology, 56, 1059–1069.PubMedGoogle Scholar
  11. De Stefano, N., Dotti, M. T., Villanova, M., et al. (1996). Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system. Brain & Development, 18, 323–326.CrossRefGoogle Scholar
  12. Donner, M., Rapola, J., & Somer, H. (1975). Congenital muscular dystrophy: A clinico-pathological and follow-up study of 15 patients. Neuropädiatrie, 6, 239–258.PubMedCrossRefGoogle Scholar
  13. Dubowitz, V. (1999). 68th ENMC international workshop (5th international workshop): On congenital muscular dystrophy, 9–11 April 1999, Naarden, The Netherlands. Neuromuscular Disorders, 9, 446–454.PubMedCrossRefGoogle Scholar
  14. Dubowitz, V. (2000). Congenital muscular dystrophy: An expanding clinical syndrome. Annals of Neurology, 47, 143–144.PubMedCrossRefGoogle Scholar
  15. Echenne, B. (1988). Congenital muscular dystrophy of a non-Fukuyama type. Brain & Development, 10, 397.Google Scholar
  16. Eeg-Olofsson, K. E. (1999). Congenital muscular dystrophy. Care of children and families. Scandinavian Journal of Rehabilitation Medicine. Supplement, 39, 53–57.PubMedGoogle Scholar
  17. Farina, L., Morandi, L., Milanesi, I., et al. (1998). Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients. Neuroradiology, 40, 807–811.PubMedCrossRefGoogle Scholar
  18. Flanigan, K. M., Kerr, L., Bromberg, M. B., et al. (2000). Congenital muscular dystrophy with rigid spine syndrome: A clinical, pathological, radiological, and genetic study. Annals of Neurology, 47, 152–161.PubMedCrossRefGoogle Scholar
  19. Fukuyama, Y., & Ohsawa, M. (1984). A genetic study of the Fukuyama type congenital muscular dystrophy. Brain & Development, 6, 373–390.Google Scholar
  20. Fukuyama, Y., Osawa, M., & Suzuki, H. (1981). Congenital progressive muscular dystrophy of the Fukuyama type – clinical, genetic and pathological considerations. Brain & Development, 3, 1–29.Google Scholar
  21. Guicheney, P., Vignier, N., Helbling-Leclerc, A., et al. (1997). Genetics of laminin alpha 2 chain (or merosin) deficient congenital muscular dystrophy: From identification of mutations to prenatal diagnosis. Neuromuscular Disorders, 7, 180–186.PubMedCrossRefGoogle Scholar
  22. Guicheney, P., Vignier, N., Zhang, X., et al. (1998). PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): Application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. Journal of Medical Genetics, 35, 211–217.PubMedCrossRefGoogle Scholar
  23. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., et al. (1995). Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genetics, 11, 216–218.PubMedCrossRefGoogle Scholar
  24. Hillaire, D., Leclerc, A., Faure, S., et al. (1994). Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Human Molecular Genetics, 3, 1657–1661.PubMedCrossRefGoogle Scholar
  25. Jones, R., Khan, R., Hughes, S., et al. (1979). Congenital muscular dystrophy: The importance of early diagnosis and orthopaedic management in the long-term prognosis. Journal of Bone and Joint Surgery. British Volume, 61, 13–17.Google Scholar
  26. Jones, K., & North, K. (2003). The congenital muscular dystrophies. In H. R. Jones, D. C. De Vivo, & B. T. Darras (Eds.), Neuromuscular disorders of infancy, childhood, and adolescence: A clinician’s approach (pp. 633–634). Philadelphia: Butterworth Heinemann.Google Scholar
  27. Kobayashi, O., Hayashi, Y., Arahata, K., et al. (1996). Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form. Neurology, 46, 815–818.PubMedGoogle Scholar
  28. Kondo, E., Saito, K., Toda, T., et al. (1996). Prenatal diagnosis of Fukuyama type congenital muscular dystrophy by polymorphism analysis. American Journal of Medical Genetics, 66, 169–174.PubMedCrossRefGoogle Scholar
  29. Kondo-Iida, E., Kobayashi, K., Watanabe, M., et al. (1999). Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Human Molecular Genetics, 8, 2303–2309.PubMedCrossRefGoogle Scholar
  30. Kondo-Iida, E., Saito, K., Tanaka, H., et al. (1997). Molecular genetic evidence of clinical heterogeneity in Fukuyama-type congenital muscular dystrophy. Human Genetics, 99, 427–432.PubMedCrossRefGoogle Scholar
  31. Leyten, Q. H., Gabreels, F. J., Joosten, E. M., et al. (1986). An autosomal dominant type of congenital muscular dystrophy. Brain & Development, 8, 533–537.Google Scholar
  32. Leyten, Q. H., Gabreels, F. J., Renier, W. O., et al. (1989). Congenital muscular dystrophy. Journal of Pediatrics, 115, 214–221.PubMedCrossRefGoogle Scholar
  33. Leyten, Q. H., Gabreels, F. J., Renier, W. O., et al. (1996). Congenital muscular dystrophy: A review of the literature. Clinical Neurology and Neurosurgery, 98, 267–280.PubMedCrossRefGoogle Scholar
  34. Lopate, G. (2009). Congenital muscular dystrophy. eMedicine from WebMD. Updated February 12, 2009. Available at: http://emedicine.medscape.com/article/1180214-overview
  35. McMenamin, J. B., Becker, L. E., & Murphy, E. G. (1982). Congenital muscular dystrophy: A clinicopathologic report of 24 cases. Journal of Pediatrics, 100, 692–697.PubMedCrossRefGoogle Scholar
  36. Mendell, J. R. (2001). Congenital muscular dystrophy: Searching for a definition after 98 years. Neurology, 56, 993–994.PubMedGoogle Scholar
  37. Misugi, N. (1980). Light and electron microscopic studies of congenital muscular dystrophy. Brain & Development, 2, 191–199.Google Scholar
  38. Moghadaszadeh, B., Desguerre, I., Topaloglu, H., et al. (1998). Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35–36. American Journal of Human Genetics, 62, 1439–1445.PubMedCrossRefGoogle Scholar
  39. Muntoni, F., & Guicheney, P. (2002). 85th ENMC international workshop on congenital muscular dystrophy. 6th international CMD workshop. 1st workshop of the Myo–Cluster project ‘GENRE’. 27–28th October 2000, Naarden, The Netherlands. Neuromuscular Disorders, 12, 69–78.PubMedCrossRefGoogle Scholar
  40. Muntoni, F., & Voit, T. C. (2004). The congenital muscular dystrophies in 2004: A century of exciting progress. Neuromuscular Disorders, 14, 635–649.PubMedCrossRefGoogle Scholar
  41. Naom, I., Sewry, C., D’Alessandro, M., et al. (1997). Prenatal diagnosis in merosin-deficient congenital muscular dystrophy. Neuromuscular Disorders, 7, 176–179.PubMedCrossRefGoogle Scholar
  42. Nass, D., Goldberg, I., & Sadeh, M. (1999). Laminin alpha2 deficient congenital muscular dystrophy: Prenatal diagnosis. Early Human Development, 55, 19–24.PubMedCrossRefGoogle Scholar
  43. Nissinen, M., Helbling-Leclerc, A., Zhang, X., et al. (1996). Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. American Journal of Human Genetics, 58, 1177–1184.PubMedGoogle Scholar
  44. Philpot, J., Sewry, C., Pennock, J., et al. (1995). Clinical phenotype in congenital muscular dystrophy: Correlation with expression of merosin in skeletal muscle. Neuromuscular Disorders, 5, 301–305.PubMedCrossRefGoogle Scholar
  45. Quijano-Roy, S., Renault, F., Romero, N., et al. (2004). EMG and nerve conduction studies in children with congenital muscular dystrophy. Muscle & Nerve, 29, 292–299.CrossRefGoogle Scholar
  46. Santavuori, P., Leisti, J., & Kruus, S. (1977). Muscle, eye, and brain disease: A new syndrome. Neuropediatrics, 8(suppl), 553–558.CrossRefGoogle Scholar
  47. Sombekke, B. H., Molenaar, W. M., van Essen, A. J., et al. (1994). Lethal congenital muscular dystrophy with arthrogryposis multiplex congenita: Three new cases and review of the literature. Pediatric Pathology, 14, 277–285.PubMedCrossRefGoogle Scholar
  48. Sparks, S., Quijano-Roy, S., Harper, A., et al. (2011). Congenital muscular dystrophy overview. GeneReviews. Updated January 4, 2011. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1291/.
  49. Takai, Y., Tsutsumi, O., Harada, I., et al. (1998). Prenatal diagnosis of Fukuyama-type congenital muscular dystrophy by microsatellite analysis. Human Reproduction, 13, 320–323.PubMedCrossRefGoogle Scholar
  50. Toda, T., Kobayashi, K., Kondo-Iida, E., et al. (2000). The Fukuyama congenital muscular dystrophy story. Neuromuscular Disorders, 10, 153–159.PubMedCrossRefGoogle Scholar
  51. Toda, T., Segawa, M., Nomura, Y., et al. (1993). Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31–33. Nature Genetics, 5, 283–286.PubMedCrossRefGoogle Scholar
  52. Tomé, F. M., Evangelista, T., Leclerc, A., et al. (1994). Congenital muscular dystrophy with merosin deficiency. Comptes Rendus de l'Académie des Sciences. Série III, 317, 351–357.Google Scholar
  53. Topaloglu, H., Renda, Y., Yalaz, K., et al. (1990). Classification of congenital muscular dystrophy. Journal of Pediatrics, 117, 166–167.PubMedGoogle Scholar
  54. Voit, T. (1998). Congenital muscular dystrophies: 1997 update. Brain & Development, 20, 65–74.CrossRefGoogle Scholar
  55. Yoshioka, M., & Kuroki, S. (1994). Clinical spectrum and genetic studies of Fukuyama congenital muscular dystrophy. American Journal of Medical Genetics, 53, 245–250.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Personalised recommendations